Timing clarification: Teradyne is scheduled to release Q2 results today, Tuesday, July 28, at 4:30 p.m. ET or later. The earnings call is tomorrow, Wednesday, July 29, at 8:30 a.m. ET. (investors.teradyne.com)
Teradyne enters Q2 with exceptionally strong AI-driven growth—but also a demanding valuation and a market focused less on the quarter being reported than on the expected second-half slowdown.
A respectable beat against Q2 estimates may not be sufficient. The likely swing factors are:
That distinction matters because Teradyne already delivered a major Q1 beat, yet its shares fell roughly 19% the following session. Investors were unwilling to extrapolate peak first-half results without better visibility into the second half.
| Metric | Company Q2 guidance | Approximate consensus | Q1 2026 actual |
|---|---|---|---|
| Revenue | $1.15B–$1.25B | $1.21B–$1.22B | $1.282B |
| Non-GAAP EPS | $1.86–$2.15 | ~$2.05 | $2.56 |
| Gross margin | 58%–59% | Around the midpoint | 60.9% |
| Non-GAAP operating margin | 30%–32% | — | 37.5% |
Consensus is essentially centered on management’s guidance rather than anticipating a major beat. At roughly $1.21 billion of revenue and $2.05 of EPS, Teradyne would deliver approximately 86% revenue growth and 260% EPS growth from Q2 2025. (investors.teradyne.com)
Q1 set an unusually high benchmark: revenue rose 87% to $1.282 billion, Semiconductor Test exceeded $1 billion for the first time, and roughly 70% of total revenue was AI-related. (investors.teradyne.com)
Management previously forecast that 55%–60% of 2026 revenue would be generated in the first half, reflecting a very strong first-half ramp in VIP compute and limited visibility beyond current customer orders.
Using the Q2 guidance midpoint:
If that represents 55%–60% of annual sales, it mathematically implies:
That is a substantial decline from the first-half quarterly run rate.
The crucial question is whether management now sees the year tracking closer to the 55% end of its first-half weighting range—which would mean a stronger second half—or the 60% end, which would imply a much deeper digestion period.
A constructive outlook would include:
A strong Q2 print paired with vague or conservative Q3 commentary could still be received poorly.
Teradyne’s first-half strength has been led by a relatively small number of large AI compute programs. Management previously described VIP compute as the most heavily first-half-weighted portion of the business, with the next major technology wave more likely in early 2027, although some orders could arrive late in 2026.
The offsetting businesses are therefore central to the thesis.
Management entered Q2 seeing strong networking demand but acknowledged that visibility into the second half was weaker than for current-quarter orders.
Key questions include:
Teradyne estimates silicon-photonics test equipment could eventually represent a $300 million–$700 million annual opportunity, but the near-term timing, test insertions and economics remain uncertain.
Memory generated $203 million in Q1, supported by HBM and DRAM test demand. Management expected memory to be more second-half weighted than compute, with additional potential from flash and data-center SSDs.
Investors should watch for:
A stronger memory outlook is probably the clearest path toward the favorable end of Teradyne’s full-year revenue range.
Q2 should include Teradyne’s first multisystem production shipments for a merchant GPU customer. Management previously said it had line of sight to approximately $50 million of merchant-GPU revenue in 2026, with low-single-digit share initially.
That contribution is modest relative to total company revenue, but the strategic implications are much larger. The initial qualification is the hardest step because Teradyne must qualify the platform and convert the supporting test libraries. Once completed, additional GPU SKUs can potentially migrate through a faster-following process.
Investors should listen for:
Management believes only low-double-digit merchant-GPU share is needed to support its long-term target model. A faster ramp would therefore represent meaningful upside—but investors should distinguish design engagement from actual production capacity orders.
Q1 gross margin reached 60.9%, benefiting from:
Management guided Q2 gross margin to 58%–59%, with approximately half the sequential decline from Q1 attributed to the absence of one-time benefits. The midpoint would still be consistent with Teradyne’s long-term target range.
The quality of any Q2 earnings beat will matter:
The operating-margin guide of 30%–32% is already very strong. The more important issue is whether margins remain structurally elevated when quarterly revenue falls below $1 billion.
Robotics generated $91 million in Q1, up 32% year over year and marking a fourth consecutive quarter of sequential growth. The segment was close to breakeven following its 2025 restructuring, while AI-related applications reached approximately 15% of Robotics revenue.
Q2 questions include:
Robotics is no longer the main driver of Teradyne’s valuation, but improved profitability would make it a useful second-half offset and reduce the drag on consolidated margins.
Product Test reported $80 million of Q1 revenue, supported by defense, aerospace and board test.
Q2 will begin to reflect two strategic transactions:
Together, the transactions required approximately $167 million of cash and were funded using Teradyne’s revolving credit facility. Investors should look for early revenue contributions, integration costs and any change to the expected earnings impact.
Other product milestones worth monitoring include:
These initiatives are unlikely to determine Q2 results, but they matter to the credibility of Teradyne’s longer-term “wafer to AI data center” strategy.
Teradyne’s growth is increasingly tied to a limited number of hyperscalers, merchant compute companies, foundries, memory suppliers and associated manufacturing partners.
In 2025:
Teradyne continued to report two greater-than-10% specifying customers and one greater-than-10% purchasing customer in Q1. (investors.teradyne.com)
This concentration can produce extraordinary operating leverage when multiple programs ramp simultaneously—as seen in Q1—but also creates significant quarterly volatility. Delays in first silicon, packaging, wafer supply, customer acceptances or other parts of an AI test cell can move tester revenue between quarters even when long-term demand is intact.
A key distinction on the call will be whether any second-half weakness represents:
At approximately $335, Teradyne has a market capitalization near $53 billion and trades at roughly 62 times trailing earnings.
The shares remain sharply higher in 2026, although they have fallen substantially from their late-June peak. The stock is therefore in an unusual setup:
Teradyne’s $6 billion revenue and $9.50–$11 non-GAAP EPS target model should not be confused with formal 2026 guidance. It is a longer-term earnings framework based on a larger automated-test-equipment market and successful execution across compute, memory, networking and related opportunities. (investors.teradyne.com)
Interpretation: The AI test cycle is broadening rather than peaking, increasing confidence that Teradyne can approach its target model earlier than expected.
Interpretation: Fundamentals remain excellent, but the stock’s reaction depends on whether the magnitude of the second-half decline is already priced in.
Interpretation: Investors begin treating first-half 2026 earnings as a temporary peak rather than the foundation for sustained growth.
Q2 itself appears well supported. The debate is about the earnings trajectory after Q2.
The most constructive result would not simply be revenue above $1.25 billion. It would be evidence that networking, memory, merchant GPU and adjacent AI-test opportunities are broadening quickly enough to make the second-half decline shallower—and shorter—than investors currently fear.
Conversely, a large Q2 beat accompanied by cautious Q3 guidance would reinforce the concern that Teradyne’s record first-half profitability represents a near-term peak. Given the valuation and the stock’s reaction to Q1, forward guidance, program timing and revenue quality should matter considerably more than the headline EPS number.